Literature DB >> 19706668

A systematic review of antibiotic dosing regimens for septic patients receiving continuous renal replacement therapy: do current studies supply sufficient data?

A M M Y Li1, C D Gomersall, G Choi, Q Tian, G M Joynt, J Lipman.   

Abstract

BACKGROUND: Drug dosing for septic patients with acute renal failure receiving continuous renal replacement therapy (CRRT) is complicated, and failure to correctly dose may result in either drug toxicity or treatment failure and development of antibiotic resistance. The aim of this study was to establish an ideal dataset that needs to be reported when presenting pharmacokinetic data for these patients and review current literature for completeness of this dataset.
METHODS: An ideal dataset was established of the parameters that should be reported when calculating a drug dosing regimen from first principles. A Medline search was performed of relevant literature producing 64 citations from which completeness of the specified criteria was examined.
RESULTS: None of the studies analysed presented the full dataset that we established as necessary. Of concern, basic pharmacokinetic parameters such as volume of distribution (V(d)) and clearance (CL) were specified in only 79% and 81% of studies, respectively.
CONCLUSIONS: A large proportion of current studies do not report key information necessary to devise a rational dosing regimen for patients with acute renal failure receiving CRRT, and we hope this dataset will be a useful guide when reporting future pharmacokinetic data.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19706668     DOI: 10.1093/jac/dkp302

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  25 in total

1.  Presence and accuracy of drug dosage recommendations for continuous renal replacement therapy in tertiary drug information references.

Authors:  Sean K Gorman; Richard S Slavik; Stefanie Lam
Journal:  Can J Hosp Pharm       Date:  2012-05

2.  Therapeutic drug monitoring of antimicrobials.

Authors:  Jason A Roberts; Ross Norris; David L Paterson; Jennifer H Martin
Journal:  Br J Clin Pharmacol       Date:  2012-01       Impact factor: 4.335

Review 3.  [Antibiotic dosing for renal function disorders and continuous renal replacement therapy].

Authors:  Erik Michael; Detlef Kindgen-Milles
Journal:  Anaesthesist       Date:  2015-04       Impact factor: 1.041

4.  Reporting Guidelines for Clinical Pharmacokinetic Studies: The ClinPK Statement.

Authors:  Salmaan Kanji; Meghan Hayes; Adam Ling; Larissa Shamseer; Clarence Chant; David J Edwards; Scott Edwards; Mary H H Ensom; David R Foster; Brian Hardy; Tyree H Kiser; Charles la Porte; Jason A Roberts; Rob Shulman; Scott Walker; Sheryl Zelenitsky; David Moher
Journal:  Clin Pharmacokinet       Date:  2015-07       Impact factor: 6.447

5.  A Robust Statistical Approach to Analyse Population Pharmacokinetic Data in Critically Ill Patients Receiving Renal Replacement Therapy.

Authors:  Sanjoy Ketan Paul; Jason A Roberts; Jeffrey Lipman; Renae Deans; Mayukh Samanta
Journal:  Clin Pharmacokinet       Date:  2019-02       Impact factor: 6.447

Review 6.  Antibiotic dosing in critically ill patients with acute kidney injury.

Authors:  Rachel F Eyler; Bruce A Mueller
Journal:  Nat Rev Nephrol       Date:  2011-02-22       Impact factor: 28.314

Review 7.  Continuous renal replacement therapies: a brief primer for the neurointensivist.

Authors:  Pritesh Patel; Veena Nandwani; Paul J McCarthy; Steven A Conrad; L Keith Scott
Journal:  Neurocrit Care       Date:  2010-10       Impact factor: 3.210

8.  Pharmacokinetic assessment in patients receiving continuous RRT: perspectives from the Kidney Health Initiative.

Authors:  Thomas D Nolin; George R Aronoff; William H Fissell; Lokesh Jain; Rajnikanth Madabushi; Kellie Reynolds; Lei Zhang; Shiew Mei Huang; Rajnish Mehrotra; Michael F Flessner; John K Leypoldt; Jennifer W Witcher; Issam Zineh; Patrick Archdeacon; Prabir Roy-Chaudhury; Stuart L Goldstein
Journal:  Clin J Am Soc Nephrol       Date:  2014-09-04       Impact factor: 8.237

9.  Influence of continuous venovenous hemofiltration and continuous venovenous hemodiafiltration on the disposition of doripenem.

Authors:  Iolanda Cirillo; Nicole Vaccaro; Dainius Balis; Rebecca Redman; Gary R Matzke
Journal:  Antimicrob Agents Chemother       Date:  2011-01-03       Impact factor: 5.191

10.  Meropenem population pharmacokinetics in critically ill patients with septic shock and continuous renal replacement therapy: influence of residual diuresis on dose requirements.

Authors:  Marta Ulldemolins; Dolors Soy; Mireia Llaurado-Serra; Sergi Vaquer; Pedro Castro; Alejandro H Rodríguez; Caridad Pontes; Gonzalo Calvo; Antoni Torres; Ignacio Martín-Loeches
Journal:  Antimicrob Agents Chemother       Date:  2015-06-29       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.